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During aging progenitor cells acquire mutations, which may generate clones that colonize the 23 
surrounding tissue. By middle age, normal human tissues including the esophageal epithelium (EE) 24 
become a patchwork of mutant clones. Despite their relevance for understanding aging and cancer, 25 
the processes that underpin mutational selection in normal tissues remain poorly understood. Here 26 
we investigated this issue in the esophageal epithelium of mutagen-treated mice. Deep sequencing 27 
identified numerous mutant clones with multiple genes under positive selection including Notch1, 28 
Notch2 and Trp53, which are also selected in human esophageal epithelium. Transgenic lineage 29 
tracing revealed strong clonal competition that evolved over time. Clone dynamics were consistent 30 
with a simple model in which the proliferative advantage conferred by positively selected mutations 31 
depends on the nature of the neighboring cells. When clones with similar competitive fitness collide, 32 
mutant cell fate reverts towards homeostasis, a constraint that explains how selection operates in 33 




Normal adult human tissues are a patchwork of clones carrying somatic mutations that progressively 37 
accumulate with age and are linked to neoplasia and other diseases 1-3. This process is exemplified 38 
by human esophageal epithelium (EE), in which mutant clones colonize the majority of normal 39 
epithelium by middle age 4,5. The commonest mutated genes are under strong positive genetic 40 
selection, meaning that there is an excess of protein-altering over silent mutations within each gene. 41 
This argues that selected mutant genes confer a competitive advantage over wild-type cells in 42 
normal esophageal epithelium 6-8. 43 
 44 
The cellular mechanisms that underpin the selection of mutant genes are not well understood. 45 
Possiblities include cell autonomous effects such as increased cell division or decreased 46 
differentiation rates and extrinsic effects due to competition between mutant and neighboring wild-47 
type cells. Cell competition involves “winner” cells out-competing their “loser” neighbors, and 48 
operates in development, aging, and cancer 9-14.  49 
 50 
The simple structure and dynamics of the murine esophageal epithelium make it an ideal model to 51 
investigate this issue. It consists of layers of keratinocytes, with progenitor (proliferating) cells 52 
residing in the lowest basal cell layer. When progenitors commit to differentiation they withdraw 53 
from the cell cycle and move into the suprabasal layers, migrating towards the epithelial surface 54 
until they are finally shed (Fig. 1a) 15.   55 
 56 
Upon division, cells generate either two progenitor daughters that remain in the basal layer, two 57 
differentiated daughters that exit the basal layer, or one cell of each type 15,16. The outcome of an 58 
individual progenitor division is unpredictable, but, on average across the tissue, the probabilities 59 
are balanced, generating equal proportions of progenitor and differentiated cells, maintaining 60 
cellular homeostasis (Extended Data 1a).  61 
 62 
Importantly, mouse esophageal epithelium progenitors lie in a continuous sheet with no barriers to 63 
limit the lateral expansion of mutant clones, which may eventually collide and compete with each 64 
other as well as with wild-type cells 4,6,8,17.  65 
 66 
Here we investigate the competitive selection of diverse somatic mutant clones in vivo. We used oral 67 
administration of diethylnitrosamine (DEN), a well characterized mutagen found in tobacco smoke, 68 
 4
to generate a patchwork of mutant clones in the mouse esophageal epithelium resembling that of 69 
older humans 18,19. By combining ultradeep sequencing and lineage tracing we resolved clone 70 
dynamics in this evolving mutational landscape. Clone dynamics depend on the mutation(s) they 71 
carry and the nature of the neighboring cells. Once an expanding mutant clone collides with cells of 72 
similar ‘fitness’, its proliferative advantage decreases, reverting towards the balanced proliferation 73 




Mutational landscape of DEN exposed esophageal epithelium 77 
 78 
We began by characterizing the mouse esophageal epithelium mutational landscape that evolved 79 
over a year following administration of the mutagen DEN, a protocol that generates only one benign 80 
hyperplastic lesion per esophagus on average (Fig. 1b) 19. Confocal imaging of the entire epithelium 81 
showed over 98% of the tissue area was histologically normal, apart from slight crowding of cells in 82 
the basal layer (Extended Data 1b-d, Supplementary Table 1).  83 
 84 
To detect mutant clones we used a sequencing approach adapted from human esophageal 85 
epithelium 4. The entire esophageal epithelium of  control and DEN-treated mice was separated 86 
from the underlying stroma and cut into a contiguous array of 2 mm2 samples (239 samples in total) 87 
(Fig. 1c). Ultradeep targeted exome sequencing (TES) of 192 genes, including those recurrently 88 
mutated in mouse and/or human squamous cancers, was performed on each sample to a median 89 
on-target coverage of 485x (Extended Data 1e, f).  90 
 91 
Mutations were called using the ShearwaterML algorithm, which detected mutant clones as small as 92 
0.018 mm2 , containing about 400 basal cells 4,20.  After merging mutations shared by adjacent 93 
samples we identified 29,491 independent somatic single nucleotide variants (SNVs) in DEN-treated 94 
mice and 66 in controls (equivalent to 122 and 0.28 events per mm2, respectively) (Fig. 1d; Extended 95 
Data 1g, Supplementary Table 2). The mutational burden was ~24 mutations per megabase 96 
compared to ~0.03 in control mice, 0.2-0.8 in normal human esophagus and 2-10 in human 97 
esophageal cancers (Fig. 1e) 4. Functionally, most mutations were protein-altering, with missense 98 
SNVs being the commonest in both DEN-treated and control samples (Fig. 1f). 99 
 100 
The mutational spectrum after DEN treatment was dominated by T>A/A>T, T>C/A>G and C>T/G>A 101 
alterations (~82% of total substitutions), with few C>G/G>C SNVs (~0.8%), typical of the DEN 102 
signature (Fig. 1g) 21,22. There were significantly more mutations in coding (untranscribed) than non-103 
coding (transcribed) strands, consistent with mutations generated from transcription-coupled DNA 104 
repair (Fig. 1h). 105 
 106 
Thus, DEN administration generates a dense patchwork of mutant clones in mouse esophageal 107 
epithelium, which appears to function normally despite a remarkably high mutation burden.  108 
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 109 
Mutational selection in DEN-treated esophageal epithelium 110 
 111 
To investigate whether the persistent mutant clones in DEN-treated mouse esophageal epithelium 112 
emerged from a competitive selection, as seen in aging human esophageal epithelium, we calculated 113 
the ratio of non-synonymous (dN) to synonymous (dS) mutations (dN/dS) across each sequenced 114 
gene using dNdScv 4,23,24. This approach controls for trinucleotide mutational signatures, sequence 115 
composition and variable mutation rates across genes. In our experiment, the dN/dS ratio indicates 116 
the likelihood of a clone carrying a non-synonymous mutation to reach a detectable size, compared 117 
with a synonymous mutation in the same gene. Protein-altering mutations that have no effect on 118 
cell behavior will have the same chance as being detected as silent mutations in the same gene, 119 
yielding dN/dS ratios of 1. Values of dN/dS<1 would indicate negative selection, resulting in clonal 120 
loss. Conversely, values of dN/dS>1 indicate the mutated gene confers a competitive advantage. We 121 
found 8 mutant genes with dN/dS ratios significantly higher than 1 (Fig. 2a; Supplementary Table 3). 122 
 123 
Of the selected genes, Notch1, Notch2, Trp53, Cul3 and Arid1a are implicated in keratinocyte 124 
progenitor cell differentiation 4,6,8,25-27. Arid1a and Kdm6a encode chromatin modifiers and are 125 
recurrently mutated in human esophageal cancer 28-30. The Adam10 protein product cleaves Notch 126 
receptors following ligand binding, and Ripk4 encodes a tumor suppressor in mouse epidermis 31,32. 127 
33-35. The known functions of the positively selected mutant genes are thus consistent with them 128 
driving clonal expansion. 129 
 130 
The most prevalent selected mutant gene was Notch1, with a total of 1,601 coding-altering 131 
mutations (Fig. 2b). We estimated clones carrying Notch1 mutations colonized over 80% of the DEN-132 
treated esophageal epithelium, whereas the remaining selected genes each covered between 1.7%-133 
19% (Fig. 2c).  The large number of Notch1 missense mutations allowed us to perform an additional 134 
test for selection by comparing the predicted and observed distributions of codon-altering 135 
mutations (Fig. 2d). Predicted codon changes were evenly distributed, but those observed were 136 
clustered in the 5 EGF repeats that form the Notch1 ligand binding domain, disrupting EGF repeat 137 
structure and/or the contact surface between Notch1 and its ligands (Figs. 2d,e; Supplementary 138 
video 1). A second cluster of mutations was seen in the Notch negative regulatory region, which is 139 
cleaved by Adam10 following ligand binding (Figs. 2d,f; Supplementary video 2) 36,37. The 140 
distribution of codon alterations thus provides further evidence of selection. 141 
 142 
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There were few spontaneously generated coding mutations in control mice, predominantly 143 
concentrated in the Notch1 gene (39/66 mutations, all non synonymous) (Extended Data 2a,b). 144 
Notch1 mutations were similarly distributed to those in DEN-treated mice (Extended Data 2c). 145 
However, mutations in the 8 positively selected genes occupied only 1.6-3.2% of the control 146 
esophageal epithelium, suggesting the tissue predominantly behaves neutrally, in agreement with 147 
published lineage tracing experiments 15,16. 148 
 149 
Comparing our results with sequencing of aging normal human esophagus showed that Notch1, 150 
Trp53, Notch2, Cul3 and Arid1a were positively selected in both species (Extended Data 1e, 2d; 151 
Supplementary Tables 4,5) 4. The similarities of the most strongly selected genes, together with the 152 
predominance and clustering of Notch 1 mutations, indicate that genetic selection in normal 153 
esophageal epithelium is convergent in mutagen-treated mouse and aging humans, despite the large 154 
differences in time scale and mutational spectrum (Extended Data 2e-h). 155 
 156 
Lineage tracing identifies clonal competition  157 
 158 
Genetic selection of mutations might be expected to alter clonal behavior. To test this, we 159 
performed genetic lineage tracing and tracked cohorts of YFP-labelled clones in control and DEN-160 
treated AhcreERTRosa26flEYFP/wt (YFP-Cre) transgenic mice (Figs. 3a,b). Following mutagen exposure, 161 
YFP-clones were generated by inducing heritable YFP expression in scattered single progenitor cells.  162 
Clonal density and size were analysed from 3D-confocal images of entire esophageal epithelia 163 
collected at different time points up to a year (Figs. 3b,c; Methods). A total of 37,528 and 21,782 164 
clones were quantified in control and mutagen-treated mice, respectively (Supplementary Table 6). 165 
The total area of labelled epithelium remained ~2% in both groups, consistent with the labelled cells 166 
being a representative subset of the entire progenitor population (Fig. 3d; Supplementary Note). 167 
 168 
In control esophageal epithelia, the number of labelled clones decreased over time, whereas the 169 
average clone area and inferred mean number of basal cells per clone grew approximately linearly 170 
with time (Figs. 3c,e-g; Supplementary Note). These features are hallmarks of neutral clonal 171 
competition between functionally equivalent progenitors, with the loss of some clones by 172 
differentiation compensated by the expansion of adjacent ones 6,15,16,19,38 (Supplementary Note). Of 173 
note, we observed a small proportion of unexpectedly large clones that may result from 174 
spontaneous mutations conferring a competitive advantage i.e. Notch1 mutants (Extended Data Fig. 175 
3a).  176 
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 177 
Compared to controls, the rate of clonal loss in mutagen-exposed esophageal epithelium was 178 
significantly increased, while the surviving clones expanded more rapidly (Figs. 3c,e-g). This indicates 179 
that the mutational landscape that evolves after DEN treatment develops from strong clonal 180 
competition causing the increased growth of “winner” mutant clones, thence eliminating more 181 
clones than in control esophageal epithelium (Supplementary Note). 182 
 183 
Mechanisms of clonal competition  184 
 185 
Next, we investigated the mechanism(s) of mutant clonal competition in the DEN-treated 186 
esophageal epithelium. As most of the mutagenized esophageal epithelium was eventually colonized 187 
by positively selected mutant clones, we expected that the behavior of most progenitor cells would 188 
diverge from normal. However, label-retaining and EdU-short term lineage tracing experiments 189 
indicated rates of cell division and stratification were not significantly different from controls 190 
(Extended Data 4; Supplementary note; Supplementary Tables 7, 8).  A further potential route of 191 
cell and clone loss is apoptosis, but this was found to be negligible in DEN-treated esophageal 192 
epithelium (0.04% of basal cells were positive for activated Caspase 3; Methods) 19. 193 
 194 
We went on to explore whether the survival and expansion of “winner” clones was determined by 195 
the mutation(s) they carry. The sequencing strategy used above cannot resolve which mutations 196 
reside in the same clone. We therefore performed whole exome sequencing (WES) of individual 197 
clones identified by genetic lineage tracing in mutagen-treated normal esophageal epithelium. 198 
Scattered single cells were genetically labelled immediately after DEN-treatment in single color YFP-199 
Cre or multicolor AhcreERTRosa26flConfetti/wt (Confetti-Cre) mice, and esophageal epithelia collected  9 200 
or 18 months later and imaged (Figs. 3a, 4a-c). 250 of the surviving larger clones (>0.005 mm2), 201 
representative of the upper 50% of the clone size distribution, were isolated under a fluorescent 202 
dissecting microscope (Figs. 4c; Extended Data 5a; Supplementary Table 9). Genomic DNA was 203 
extracted from each clone and split into three pools, each of which underwent independent whole 204 
genome amplification (WGA) and WES to an average coverage per replicate of 186x (Figs. 4c,  205 
Extended Data 5b). To exclude artefactual SNVs generated during WGA, only mutations shared by 206 
all three amplified triplicates with a variant allele frequency (VAF)>0.3, indicating they were clonal or 207 
near clonal, were included in the analysis (Extended Data 5c; Supplementary Table 10). 208 
 209 
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After applying these conservative criteria, we identified a total of 100,544 SNVs (Supplementary 210 
Table 11). The spectrum and functional impact of mutations were consistent with targeted exome 211 
sequencing (Extended Data 5d-f). The median number of SNVs/exome for isolated clones was 433 212 
(Figs. 4d,e), 5-10 fold higher than in aging normal human esophageal epithelium 5. Most mutations 213 
were protein-altering, with up to 72 protein-truncating mutations across the exome per clone (Fig. 214 
4e).  215 
 216 
65% of the clones carried mutations in one or more of the 8 selected genes identified by TES (Fig. 217 
4f). Despite the small number of clones sequenced, dN/dS analysis showed Notch1, Notch2 and 218 
Adam10 were positively selected (Extended Data 5g,h; Supplementary Table 12). No other selected 219 
genes were detected. Most clones (53.6%) carried 1-2 positively selected mutations, ranging from 0 220 
to 5.  Adam10 mutations were significantly more likely to occur in Notch1 wild-type clones (p= 1.5 × 221 
10-5, Fisher’s exact test with multiple test correction), consistent with Adam10 mutations being an 222 
alternative route to decreasing Notch signaling (Fig. 4f). 223 
 224 
We expected that the largest clones would carry the most strongly selected driver mutations. 225 
However, there was no correlation between the size of the sequenced clones and the total number 226 
of mutations per clone, the number of non-synonymous driver mutants per clone or the presence of 227 
individual driver mutations (Figs. 4g-i). This may reflect the late time points analyzed, and we may 228 
speculate that at an early stage, strongly selected mutant clones would be expanding in a 229 
background of cells of lower competitive fitness and that clone size may indeed reflect the fitness 230 
conferred by the mutation(s) it carries6. 231 
 232 
We also looked for clonal copy number alterations (CNAs), which are rare in normal human 233 
esophageal epithelium but common in esophageal cancers 4,5. Only 4 out of the 250 clones showed 234 
evidence of limited CNAs, indicating that clonal expansion in the mutagen-treated mouse 235 
esophageal epithelium is not driven by chromosomal alterations (Extended Data 6). 236 
 237 
Collectively, these findings confirm that clones carrying positively selected mutations spread widely 238 
in the esophageal epithelium. However, the mutations carried by a clone do not appear to be the 239 
sole factor determining clone size. In addition, the average rates of basal cell division and 240 
stratification remained almost unchanged following mutagen treatment, despite genetic and lineage 241 
tracing evidence of strong selection (Figs. 2, 3). We next set out to investigate how these 242 
observations may be reconciled. 243 
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 244 
Mutant cell fate depends on fitness of neighboring cells  245 
 246 
To further explore cellular mechanisms of competition we drew on previous insights into normal and 247 
mutant progenitor cell behavior in murine esophageal epithelium. In homeostasis, dividing 248 
progenitor cells have an equal chance of generating progenitor or differentiating daughters 249 
(Extended Data 1a) 15. A common feature of transgenic Notch and p53 mutant keratinocytes in a 250 
background of wild-type cells is an imbalance in division outcome, so the average mutant cell 251 
division produces more progenitor than differentiating daughters, thus increasing the mutant 252 
population 6,8. This gives mutant clones an advantage even if the rate of cell division is unchanged 253 
(Extended Data 1a). We hypothesized that such a mechanism may operate in mutagen-treated 254 
esophageal epithelium (Supplementary Note). 255 
 256 
A second key observation from Notch and p53 mutant progenitors is that, in the long term, their fate 257 
reverts towards the balance of normal homeostasis. This allows clones to persist in a normal-258 
appearing epithelium in which the only abnormality is a modest increase in basal cell density, like 259 
that observed following DEN treatment 6,8. Competition in a normal epithelium is thus a zero-sum 260 
game in which clonal expansion is limited by the tissue finite size (Supplementary Note). 261 
 262 
We speculated that the fate of DEN-mutated progenitors may depend on the genotype of 263 
neighboring cells (Fig. 5a; Supplementary Note). Initially, a driver mutant progenitor is surrounded 264 
by wild-type cells and shows a fate bias towards proliferation, leading to clonal expansion as wild-265 
type cells are outcompeted at the clone edge. After this, mutant clones will begin to collide with 266 
each other, competing for space, so that eventually they become surrounded by similarly 267 
competitive mutants, at which point their cell fate reverts towards balance.  268 
 269 
To explore this neighbor-contrained fitness (NCF) hypothesis quantitatively, we developed a two-270 
dimensional lattice-based model, where cell division occurs at random and leads to replacement of 271 
an adjacent cell. Fitness differences manifest in different likelihoods of adjacent wild-type and 272 
mutant cells to be lost by differentiation (Fig. 5a; Extended Data 7; Supplementary Note). 273 
Simulations of the dynamics of clones carrying a neutral mutation in a pure wild-type environment 274 
reproduced the features of neutral clonal competition observed in control animals (Figs. 3e,f; 5b-e; 275 
Supplementary video 3). We next simulated a single highly competitive mutation expressed in 276 
scattered single cells within a wild-type epithelium (Figs. 6a top panels, 6b; Supplementary video 4). 277 
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We compared the results of this simulation with a transgenic mouse experiment in which the highly 278 
competitive dominant negative mutant allele of Maml-1 fused to GFP (DN-Maml1), that inhibits 279 
Notch signaling, was induced in single progenitors (Figs. 6c, Extended Data 8a) 6. DN-Maml1 280 
expressing cells outcompeted wild-type cells, generating rapidly expanding clones (Figs. 6d left 281 
panel, 6e). Despite its simplicity, the NCF model recapitulates the main features of both the short- 282 
and long-term dynamics of clones carrying a single neutral or a highly competitive mutant growing in 283 
a wild-type background. 284 
 285 
Having validated the NCF hypothesis in these simple scenarios, we explored clonal competition in 286 
mutagen-treated esophageal epithelium (Supplementary Note). A simple setting, in which mutant 287 
cells were assigned the same fitness value, produced results consistent with the behavior of YFP-288 
labelled clones in DEN-treated esophageal epithelium, both in terms of clone size and the proportion 289 
of clones that persisted over time (Figs. 3e,f; 5b-e; Supplementary Note). From a theoretical 290 
perspective, clone size distributions adopt a characteristic exponential form under neutral drift, seen 291 
in both control experimental and simulated results (Fig. 5c; Supplementary Note). Notably, 292 
experimental YFP-labelled clones showed a broader distribution of sizes following mutagen 293 
treatment, which curved and became enriched in larger clones at intermediate time points before 294 
collapsing back towards an exponential-like form at the one-year time point. Simulations under 295 
different parameter values indicated this change in the form of the distribution of clone sizes occurs 296 
concomitantly with the onset of confluence of highly competitive driver clones in the tissue (Figs. 297 
5b; Supplementary video 3; Supplementary Note). This behavior suggests that dynamics in the 298 
mutated epithelium revert towards neutrality due to clonal interactions following a transient period 299 
of strong competition and selection. This is consistent with the lack of a correlation between the 300 
presence of strongly selected mutants and clone size (Figs. 4g-i). Taken together, simulated and 301 
experimental data argue that the dynamics of mutant clones in the mutagen treated esophageal 302 
epithelium are driven by neighbor-constrained fitness. 303 
 304 
Validation of the neighbor-constrained fitness model 305 
 306 
A strength of the NCF hypothesis is that it makes testable predictions. One prediction is that the 307 
expansion of mutant clones will vary according to the surrounding mutational patchwork, as their 308 
growth is conditional on their fitness relative to adjacent clones (Figs. 6a,b,f; Supplementary video 309 
4). To test this, we performed lineage tracing in conditional DN-Maml1 mice, tracking the expansion 310 
of the highly competitive DN-Maml1 mutant clones in animals previously treated with DEN (Fig. 6c). 311 
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DN-Maml1 clone growth was constrained in the DEN-treated epithelium compared with untreated 312 
mice (Figs. 6d,e; Supplementary Table 13). This was presumably due to DN-Maml1 mutant clones 313 
colliding with other clones carrying DEN-induced mutations of similar competitive fitness, such as 314 
those carrying Notch1 mutations (Fig. 2), at which point they would revert towards neutral 315 
competition (Fig. 5a). Comparison of clone size distributions in DEN-treated YFP versus DN-Maml1 316 
mice demonstrated that the initial growth advantage of DN-Maml1 over neutral YFP-labelled clones 317 
within a highly mutated environment decreases over time, arguing that expanding clones do indeed 318 
revert towards neutrality when they encounter similarly competitive clones (Extended Data 8b,c; 319 
Supplementary Table 14). Together, the simulations and experimental results indicate that mutant 320 
clone growth is influenced by the genotype of the surrounding clones. 321 
 322 
A further prediction is that clone growth would be expected to occur predominantly at the edges of 323 
mutant clones, where progenitors may encounter less fit neighbours (Fig. 7a). In the center of the 324 
clone all cells are genetically identical and have no fitness advantage over their neighbours. This 325 
prediction was tested in silico by simulating the expansion of highly competitive single mutant clones 326 
and the subsequent random labelling of single cells within them (Fig. 7b). The results indicated that 327 
the labelled subclones indeed grew faster when they were located at the borders rather than in the 328 
center of the mutant clones (Figs. 7c,d; Supplementary Video 5). To validate the simulations, we 329 
generated a new mutant mouse strain: Ahcre
ERT
Rosa26flConfetti/DNMaml-GFP (Confetti-DN-Maml1). These 330 
animals carry a conditional reporter that labels cells with one of 4 colors after induction, as well as 331 
the DN-Maml1 allele (Extended Data 8d). Confetti labelling occurs at a much lower frequency than 332 
DN-Maml1 recombination, allowing visualization of labelled clones in both wild-type and DN-Maml1 333 
expressing areas. We induced Confetti-DN-Maml1 animals and collected the esophagus 1 month 334 
later (Fig. 7e). Confetti clones lying within DN-Maml1 expressing areas were significantly smaller 335 
than those in contact with wild-type cells at DN-Maml1 boundaries (Figs. 7f,g; Supplementary Table 336 
15). 337 
 338 
Taken together, the results above show that the NCF model defines and predicts the global 339 
dynamics and behaviour of clones in mutated epithelium, arguing that the competitive ‘fitness’ of 340 





Resolving the processes that underpin the competitive selection and generate the mutational 345 
patchwork of aging normal human epithelium has proved challenging. The interpretation of ultra-346 
deep targeted sequencing data from human epithelia has generated controversy, and a recent 347 
analysis suggests that determining the presence of selection by using allele frequencies is 348 
problematic due to uncertainties in estimating clone sizes and the effects of clonal competition 17,39-349 
41. The mouse model described here enables us to investigate these issues. Mutagen treated 350 
esophageal epithelium has several features in common with aging human tissues, despite the 351 
differences in mutational processes and timescale of clonal competition between the two species. 352 
Other than a small increase in basal cell density, the mutagen-treated mouse esophageal epithelium 353 
remains histologically intact and functions normally like in humans, with no global change in cell 354 
proliferation or stratification rates. This is despite the esophageal epithelium being extensively 355 
colonized by cells carrying mutations that promote clone expansion as evidenced by strongly 356 
positive dN/dS ratios. The mutations under selection in mice include the commonest drivers in 357 
human esophageal epithelium. Notably, Notch1 mutants replace the majority of esophageal 358 
epithelium in both mice and older humans, and the distribution of missense mutants across the 359 
protein is almost identical. These similarities lead us to speculate that the same processes may 360 
underpin clonal competition in mouse and human esophageal epithelium. It seems likely similar 361 
principles also operate in other tissues where clones collide within the proliferating cell 362 
compartment such as the epidermis, liver and endometrium 3,4,8,42. 363 
 364 
The selection of mutations cannot be explained by the cell autonomous effects alone 8,27,40,41.  The 365 
NCF hypothesis highlights the key role of cell competition at clonal boundaries in shaping the 366 
mutational patchwork of mutagenized esophageal epithelium, although it is agnostic to the detailed 367 
competitive mechanism(s). These may include mutant cells driving the differentiation of neighbors, a 368 
type of ‘super competition’ observed with Notch inhibiting mutant clones in esophageal epithelium 369 
6,7,43. An alternative mode of competition is the killing of neighboring cells, but we found no evidence 370 
supporting this mechanism 6,8,10,19,27. The molecular basis of cells responding to the genotype and 371 
‘fitness’ of their neighbors may involve cell-cell signals (such as Notch) and/or cytoskeletal and 372 
metabolic pathways 6,44,45. The mechanisms that lead to the reversion of a biased mutant cell fate 373 
towards a balanced one are not known but may be mechanical. Indeed, cell density is a highly 374 
conserved regulator of cellular homeostasis in diverse epithelia 46-48. Crowding of keratinocytes 375 
promotes their differentiation and is associated with reversion of mutant cell fate towards balance 376 
in esophageal epithelium 6,49,50.  377 
 378 
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What is the significance of the neighbor regulated fitness for cancer prevention? If, as seems likely, 379 
the risk of transformation varies with the size of the population of cells carrying mutations that 380 
promote malignancy, reducing the burden of oncogenic mutants may have long term benefit in 381 
cutting cancer risk. Reducing competitive fitness of one such mutant, p53, in a wild-type background 382 
results in loss of p53 mutant clones as they are displaced by adjacent wild-type cells with a relative 383 
proliferative advantage 27. Other colonizing mutations such as Notch1 may protect against malignant 384 
transformation 4,5. Interventions aimed at reducing cancer risk will need to preserve the 385 
competitiveness of beneficial mutants. Understanding that a complex mutational patchwork is 386 
generated by a simple cell competition framework will guide such preventative strategies. 387 
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Figure legends 545 
 546 
Figure 1. The mutational landscape of normal EE in control and DEN-treated mice. a, Mouse 547 
esophageal epithelium (EE). Progenitor cells are confined to the basal layer. Differentiating cells exit 548 
the cell cycle, migrate out of the basal layer, through the suprabasal layers and are finally shed into 549 
the esophageal lumen. b, Protocol: wild-type mice were treated for 2 months with 550 
diethylnitrosamine (DEN) or vehicle and the esophagus collected 12 months later. c, Sequencing 551 
protocol: EEs from 3 control and 3 DEN-treated mice were cut into a contiguous grid of 2mm2 pieces, 552 
DNA extracted from each sample and ultradeep targeted sequencing performed. Mutations were 553 
called with the Shearwater algorithm. Mutant clones spanning adjacent samples were merged for 554 
analysis. d, Number of mutations per sample (each dot represents a sample). e, Estimated mutation 555 
burden in the 3 control and 3 DEN-treated EEs, bars indicate mean ± SEM (p value is with unpaired 556 
two-sided Student’s t-test). f, Percentage of mutation types identified in control and DEN-treated 557 
mouse EE. g, Mutational spectrum of DEN-treated samples. The bar plot illustrates the percentage of 558 
mutations in each of the 96 possible trinucleotides (mean ± SEM, n=3 mice). h, Strand asymmetry. 559 
Total substitutions in the coding (untranscribed, striped-bars) and non-coding (transcribed, solid-560 
bars) strands for each mutation type in DEN-treated EE. Number of mutations in non-coding/coding 561 
strands: C>A = 1372/2098, C>G = 112/179, C>T = 3327/5200, T>A = 2963/7475, T>C = 4450/7154, 562 
T>G = 918/2041. Two-sided Poisson test. Sequencing data is detailed in Supplementary Table 2. 563 
VAF, variant allele frequency.  564 
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Figure 2. Positive selection of somatic mutations in DEN-treated EE. a, dN/dS ratios for missense 565 
and truncating (nonsense + essential splice site) substitutions and insertions or deletions (indels) 566 
indicating genes under significant positive selection in normal EE from DEN-treated mice (29,491 567 
mutations; q<0.05, R package dndscv24). Data and statistics are available in Supplementary Table 3. 568 
b, Number and type of mutations in the significantly positively selected genes. c, Estimated 569 
percentage of DEN-treated EE carrying non-synonymous mutations for each gene. d, Number of 570 
missense mutations/codon within Notch1. Blue line is the expected distribution calculated from the 571 
mutational spectrum of DEN and the Notch1 coding sequence; red line is the observed distribution. 572 
Mutations were clustered in the extracellular EGF8-EGF12 repeats that form the Notch 1 ligand 573 
binding domain (light orange shadow) and in the negative regulatory region (NRR) of Notch1 (light 574 
purple shadow). e-f, 3D structures of the highly mutated regions. e, Ligand binding domain showing 575 
NOTCH1 bound to JAGGED1 (Protein Data Bank code: 5UK5); see also Supplementary video 1. f, 576 
NRR domain and cleavage site for NOTCH1 after ligand binding (Protein Data Bank code: 3ETO), see 577 
also Supplementary video 2. Recurrently mutated codons were: cysteine residues in disulfide bonds 578 
(blue), leucine to proline in β-sheets (orange), mutations affecting D469 (cyan), mutations of calcium 579 
binding residues (red) and mutations on the ligand binding interface (green), all predicted to disrupt 580 
the protein structure or the binding to the ligand.581 
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Figure 3. Lineage tracing reveals hallmarks of strong clonal competition in DEN-treated EE. a, In 582 
vivo genetic lineage tracing using AhcreERTRosa26flEYFP/wt reporter mice. Cre-mediated excision of the 583 
stop codon by tamoxifen (TAM) and ß-napthoflavone (BNF) injection results in the heritable 584 
expression of yellow fluorescent protein (YFP), generating YFP-labelled clones. b, Protocol: 585 
AhcreERTRosa26flEYFP/wt mice were treated with DEN or vehicle control for 2 months, followed by 586 
clonal labelling. EE was collected at the indicated time points. c, Representative 3D-projected 587 
confocal images of control and DEN-treated EE collected at the indicated time points. Nuclear (DAPI) 588 
staining is blue and YFP-labelled clones are yellow. Insets are enlarged views of dashed areas. Scale-589 
bars: main panels 1mm, insets 200µm. d, Percentage of EE area labelled. Shaded areas indicate 590 
mean and 95% confidence bounds across all time points. Each dot represents a mouse, error-bars 591 
correspond to mean ± SEM (see n numbers below). e-f, Number of clones per mm2 of EE (e) and 592 
average area of clones (f) in control and DEN-treated mice collected at the indicated time points. 593 
Shading indicates the difference between the fitted curves. Each dot represents a mouse. Error-bars: 594 
mean ± SEM (p values from two-sided Student’s t-test; see n numbers below). g, Violin plots 595 
depicting the distributions of individual clone areas in control and DEN-treated mice. Lines show 596 
median and quartiles. p values are from two-sided two-sample Kolmogorov-Smirnov test. Number of 597 
mice (clones) for d-g (control/DEN): 10d = 2/3 (11552/15092), 1m = 5/3 (15865/5682), 3m = 3/3 598 
(4152/539), 6m = 6/4 (2474/281), 12m = 5/3 (3485/188). See Supplementary Table 6. 599 
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Figure 4. Whole exome sequencing of single clones isolated from DEN-treated mice EE. a, In vivo 600 
genetic lineage tracing using AhcreERTRosa26flConfetti/wt mice. TAM and BNF injections activate Cre-601 
mediated inversion and excision recombination events in scattered single cells, conferring heritable 602 
expression of one of the four fluorescent proteins (YFP, GFP, RFP and CFP), resulting in labelled 603 
clones. b, Protocol: Single color AhcreERTRosa26flEYFP/wt (Fig. 3a) or multicolor AhcreERTRosa26flConfetti/wt 604 
mice received DEN for 2 months, followed by clonal labelling and tissue collection at the indicated 605 
time-points. c, Individual labelled clones were whole exome sequenced in triplicate. Scale bars 606 
=1mm. d, Number of synonymous (light colored) and non-synonymous (dark colored) mutations per 607 
clone (each mouse is shown in different colors), ranked by mutation burden (n=250 clones from 12 608 
mice). e, Number of total, synonymous, non-synonymous and truncating (nonsense + essential splice 609 
site) mutations per clone (each dot represents a clone, n=250 clones), red line indicates median with 610 
95% CI. f, Combinations of non-synonymous mutations in the 8 positively selected genes (see Fig. 611 
2a) within individual clones. The percentage of clones mutant for each gene is indicated. g-h, 612 
Correlation between the area of individual clones and the number of mutations (g) or the number of 613 
non-synonymous mutations in the 8 selected genes (h). Fitted lines indicate linear regression 614 
(Pearson r; (g): r2=0.02, p = 0.1; (h): r2=0.003, p = 0.5; n=121 clones). i, Area of clones carrying 615 
mutations (non-exclusively) in the indicated genes (mean ± SD, sample size indicated in brackets). 616 
See Supplementary Table 11.  617 
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Figure 5. The “neighbour-constrained fitness” (NCF) model. a, In the NCF model, progenitor cell 618 
division (bold outline) is linked to a neighboring cell differentiating and exiting from the basal layer. 619 
Mutations in neighboring cells may determine their likelihood of differentiating. When all neighbor 620 
cells are equivalent, either wild-type (left) or mutant (right), they all have equal probability of 621 
differentiation. When neighboring cells differ in their probability of differentiating (e.g. at mutant 622 
clone edges), cells with higher probability of differentiation are “losers” whereas those with a lower 623 
likelihood of differentiation will, on average, ‘win’ and persist (Supplementary Note). b, Simulations 624 
of wildtype (top) or mutant (bottom, mimicking an in vivo DEN treatment scenario) clones growing 625 
over time. Each colour represents a labelled clone. A simple setting was considered, with all mutant 626 
cells assigned the same fitness value (δ^M). Pie charts indicate the total fraction of mutated 627 
epithelium. See Supplementary Note. c, Cumulative distributions of clone sizes normalized by the 628 
average clone area at each time point, in control and mutagen-treated conditions. Experimental 629 
data (top panels) is shown as mean frequency ± SEM. Number of clones (control/DEN): 630 
10d=11552/15092, 1m=15865/5682, 3m=4152/539, 6m=2474/281, 12m=3485/188. Results from 631 
the theoretical model simulations are displayed below (shaded areas correspond to 95% plausible 632 
interval frequencies from n=90.000 competing clones). d-e, NCF model predictions for the average 633 
clone size (d) and clone density (e) over time (shaded areas are 95% plausible intervals, n=90.000 634 
clones). A  simple setting was considered, with all mutant cells assigned the same δ^M. See 635 
supplementary Note. 636 
  637 
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Figure 6. Clonal growth is conditional to their fitness relative to surrounding clones. a, Simulations 638 
of the expansion of high-competitive single mutant clones (green) induced within a wildtype 639 
environment (top) or within a highly mutated landscape (bottom), equivalent to that in DEN-treated 640 
mice (pale colors indicate mutant clones). In the later, every initial mutant cell is given a different 641 
competitive fitness, with δ^M randomly drawn from a distribution F=(1-Gamma(κ,1/κ)), with shape 642 
determined by parameter κ. Pie charts indicate the fraction of mutated epithelium. b, Simulated 643 
clonal expansion for highly competitive single mutant clones generated within a wildtype or a 644 
mutated environment, as in a. c, Protocol: AhcreERTRosa26wt/DNM-GFP (MAML-Cre) mice (Extended 645 
Data 8a) received DEN or vehicle control for 2 months followed by clonal labelling. Tissues were 646 
harvested at the indicated time points. d, Confocal images of control and DEN-treated MAML-Cre 647 
EEs collected at the indicated time points post-induction (blue = DAPI, green = DN-Maml1). Scale-648 
bars: 1mm. e, Percentage of EE covered by DN-Maml1 clones in control and DEN-treated MAML-Cre 649 
mice, collected at the indicated time points (shadow indicates differences between averages). Each 650 
dot represents a mouse (mean ± SEM). Number of mice (control/DEN): 10d=3/3, 1m=3/5, 3m=4/3, 651 
6m=3/4, 12m=3/3. See Supplementary Table 13. f, Schematic of the behaviour of mutant clones in 652 
the presence of wild type (top; black area represent wild-type clones) or other mutant clones 653 
(bottom; coloured areas represent clones carrying different mutations). Expansion of a particular 654 
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Figure 7. A competitive advantage at clone borders drives clonal dynamics in the DEN-treated EE. 660 
a, The neighbor-constrained fitness model implies that competitive mutant cells have an advantage 661 
over wild-type or less fit mutants that is neutralised when cells are surrounded by equally fit cells, so 662 
that expansion of highly competitive (“fit”) clones takes place at boundaries with “weak” clones. b, 663 
Simulation protocol to analyse the expanding behaviour of clones enclosed within or at the edges of 664 
mutant clones. c, Representative image of the simulations from (b) showing subclones (in red or 665 
yellow) growing within the mutant (green) clone (arrow) or at the edge of the clone, in contact with 666 
other wildtype clones depicted as black areas (arrowhead). d, Quantification of the simulations from 667 
(b) showing the size of subclones growing enclosed within (n=188) or at the edges (n=200) of mutant 668 
clones (from a 30,000-cells lattice simulation). Lines show median and quartiles. Two-sided Mann-669 
Whitney test. See Supplementary video 5. e, Protocol: AhcreERTRosa26flConfetti/DNM-GFP mice (Extended 670 
Data 8d) were induced and the esophagus collected 1 month later. f, Representative image of EE 671 
tissues from (e) depicting the size of confetti labelled clones (red and yellow) in the edge of 672 
(arrowheads) or enclosed by (arrows) DN-Maml1 mutant areas (green). Scale bars: 50µm. g, Violin 673 
plots showing the area distribution of confetti clones quantified at the edge (n=493) or enclosed 674 
(n=434) within DN-Maml1 areas (from 6 mice/group). See Supplementary Table 15. Lines show 675 
median and quartiles. Two-sided Mann-Whitney test.676 
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METHODS ONLINE 677 
 678 
Animals. All experiments were conducted according to the UK Home Office Project Licenses 679 
70/7543, P14FED054 or PF4639B40. Male and female adult mice were used for in vivo experiments. 680 
Animals were housed in individually ventilated cages and fed on standard chow. Double mutant 681 
AhcreERTRosa26flEYFP/wt, R26M2rtTA/TetO–HGFP, AhcreERTRosa26flConfetti/wt and AhCreERTRosa26flDNM−GFP/wt 682 
animals on a C57BL/6N background were generated as described previously 1-4. Triple mutant 683 
AhCreERTR26flDNM−GFP/Confe  mice were generated by crossing AhcreERT, R26flConfetti/wt and R26flDNM−GFP/wt 684 
mice. C57BL/6N wild type mice were also used as indicated. 685 
 686 
Chemically induced mutagenesis. To generate mutations in the esophageal epithelium, mice were 687 
treated with Diethylnitrosamine (DEN, Sigma Cat# N0756) in sweetened drinking water (40 mg per 688 
1,000 ml) for 24 hours 3 days a week (Monday, Wednesday and Fridays) for 8 weeks 2. After each 689 
dosage mice received sweetened water until the next DEN treatment. Control mice received 690 
sweetened water as vehicle for the length of the treatment. After the 8 weeks, all mice were 691 
administered normal water until the collection date. 692 
 693 
Whole mount sample preparation. Mouse esophagus was dissected, cut longitudinally and the 694 
muscle layer removed by gently pulling with forceps. The entire tissue was then incubated for 2–3 h 695 
in 5 mM EDTA at 37°C before separating the epithelium from the underlying submucosa with fine 696 
forceps. The whole epithelium was then flattened and fixed in 4% paraformaldehyde for 30 min at 697 
room temperature. Tissues were then washed in PBS and stored at 4°C.   698 
 699 
Tissue immunostaining. For tissue immunostaining, wholemounts were blocked for 1 hour in 800μl 700 
of staining buffer (0.5% bovine serum albumin, 0.25% fish skin gelatin, 0.5% Triton X-100 in PBS and 701 
10% donkey serum). Where needed samples were incubated with primary antibodies (anti GFP/YFP, 702 
Thermo Fisher Scientific Cat# A10262; anti Active Caspase 3, Abcam Cat#Ab2302; Alexa Fluor® 647 703 
anti-mouse CD45 Antibody, Biolegend Cat# 103124; anti Cytokeratin 14, Covance Cat# PRB-155P)  in 704 
staining buffer overnight at room temperature, followed by 4 washes of 20min with 0.2% Tween-20 705 
in PBS. Samples were then incubated with secondary antibodies (Alexa Fluor 488 Donkey Anti-706 
Chicken, Jackson ImmunoResearch Cat# 703-545-155; Alexa Fluor 555 Donkey Anti-Rabitt, Thermo 707 
Fisher Scientific Cat# A-31572) in staining buffer for 3h at room temperature and washed as above. 708 
Finally, tissues were incubated overnight at room temperature with 1 μg/ml DAPI or 0.4μM TO-709 
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PRO™-3 Iodide solution (Thermo Fisher Scientific, Cat# T3605) to stain cell nuclei and mounted using 710 
VECTASHIELD Mounting Media. 711 
 712 
Confocal microscopy. Images were acquired on a Leica TCS SP8 (Leica Microsystems) confocal 713 
microscope using ×10, ×20 or ×40 objectives. Typical settings for acquisition of z stacks were optimal 714 
pinhole, line average 3–4, scan speed 400-600 Hz and a resolution of 512 x 512 or 1,024 × 1,024 715 
pixels. Visualisation and image analysis were performed using IMARIS (bitplane), ImageJ or Volocity 716 
3D Image Analysis Software (Perkin Elmer). 717 
 718 
Histology. The esophagus from control and DEN-treated mice (12 months post-DEN) were dissected, 719 
fixed in 10% formalin for at least 24h and stored at 4°C. Tissues were then embedded in paraffin and 720 
cut at 5 µm thickness. Sections were stained with hematoxylin and eosin and scanned. 721 
 722 
Basal cell density. The basal cell density of the esophageal epithelium was measured at different 723 
time points in control and DEN-treated mice. Whole-mounted tissues were analysed by confocal 724 
imaging and the number of DAPI+ basal cells per field of view was quantified from 7-10 random 725 
images per animal (2-3 animals per condition and time point). 726 
 727 
Number of surrounding basal cells. Confocal images of mouse esophageal epithelium stained with 728 
Dapi and Cytokeratin 14 were used to measure the number of neighbouring cells per basal layer cell.  729 
For this, 100 basal cells per mouse were randomly selected from 10 different images, and the 730 
number of neighboring cells manually counted. A total of 400 cells from 4 mice were measured. 731 
 732 
In vivo clonal lineage tracing. To genetically label clones we crossed the appropriate floxed reported 733 
mouse lines (Rosa26flEYFP/wt, Rosa26flConfetti/wt, Rosa26flDNM−GFP/wt or Rosa26flDNM−GFP/Confe ) with 734 
conditionally inducible AhCreERT mice. In these strains, the relevant fluorescent reporters can be 735 
genetically induced following treatment with ß-napthoflavone (BNF, MP Biomedicals Cat# 156738) 736 
and tamoxifen (TAM, Sigma Aldrich Cat# N3633). Specifically, transcription of the Cre mutant 737 
estrogen receptor fusion protein (CreERT) is induced following intraperitoneal (i.p) BNF injection. A 738 
subsequent i.p injection of TAM is necessary in order for the CreERT protein to gain access to the 739 
nucleus and excise the loxP flanked “STOP” cassette resulting in the expression of the relevant 740 
reporter. As the switch occurs at the gene level, the descendants of the originally labelled cell 741 
(clones) will also constitutively express the reporter and can be visualised by fluorescent microscopy. 742 
The dose of BNF and TAM can be titrated to label only a small percentage of cells (clonal labelling) to 743 
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avoid fusion events when the clones expand over time (see details for each strain below). 10-16 744 
week old mice were used for the lineage tracing experiments. 745 
 746 
YFP clones. AhcreERTR26flEYFP/wt (YFP-Cre) mice were used for clonal labelling of the EE with YFP 747 
fluorescent protein (Fig. 3a). YFP expression was clonally induced by a single injection of 80 mg kg 748 
BNF and 1 mg TAM to mice control or previously treated with DEN for 2 months. Esophagus from 749 
induced mice were collected at different time points (10 days, 1, 3, 6 and 12 months) post induction, 750 
peeled, fixed and stained with DAPI as described above (Whole mount sample preparation and 751 
Tissue immunostaining). Whole EEs were imaged by confocal microscopy and the number of clones 752 
as well as the projected YFP clone areas were measured from these images as described below (YFP 753 
clones number and projected areas). 754 
 755 
Confetti clones. AhcreERTR26flConfetti/wt mice were used to clonally label cells with one of four different 756 
fluorescent proteins (YFP, GFP, RFP or CFP) (Fig. 4a). Animals were treated with DEN in drinking 757 
water for 2 months followed by a single i.p injection of BNF (80 mg kg) and TAM (1mg) to clonally 758 
induce cell labelling. 9 or 18 months later mice were culled and the esophagus dissected. Whole 759 
mount EEs were processed as described above (Whole mount sample preparation). Fluorescent 760 
clones were imaged and their areas measured using Volocity 3D Image Analysis Software (Perkin 761 
Elmer). Selected individual confetti clones were then extracted and processed for DNA whole exome 762 
sequencing as described below (Confetti clone cutting and sequencing).  763 
 764 
DN-Maml1 clones. AhcreERTR26flDNM−GFP/wt mice were used for clonal induction of the dominant 765 
negative mutant of Maml1 (DN-Maml1) (Extended Data 8a). This mutant inhibits Notch intracellular 766 
domain induced transcription, therefore disrupting the Notch signalling pathway 4. It is also fused to 767 
GFP, which allows for clonal labelling of the mutant. Clonal induction of DN-Maml1 was achieved by 768 
a single injection of BNF (0.08 mg/Kg) and TAM (0.25mg) to control or DEN-treated mice. Esophagus 769 
were collected at different time points (10 days, 1, 3, 6 and 12 months) after induction. Tissues were 770 
processed, stained with anti-GFP antibody and imaged on a confocal microscope as described above 771 
(Whole mount sample preparation, tissue immunostaining and Confocal microscopy). The coverage 772 
(% of the total EE occupied by mutant clones) of DN-Maml1 clones was measured using Volocity 3D 773 
Image Analysis Software (Perkin Elmer).  774 
 775 
Confetti-MAML clones. AhcreERTR26flDNM−GFP/Confe  mice (Extended Data 8d) were generated to 776 
analyse the relative growth of Confetti clones located either at the edges of or enclosed within DN-777 
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Maml1 mutant areas. For this purpose we took advantage of the higher recombination efficiency of 778 
DN-Maml1 as compared to the Confetti reporter. AhcreERTR26flDNM−GFP/Confe  mice were induced with 779 
a single injection of 80 mg/kg BNF and 1 mg TAM, and esophagus collected 1 month later. This dose, 780 
higher than the one used for the clonal labelling of AhcreERTR26flDNM−GFP/wt mice, generates a large 781 
amount of DN-Maml1 mutant clones, with only a small percentage of them also expressing the 782 
Confetti reporter. The possible outcomes following this high induction are as follows: either single 783 
induction of DN-Maml1, single induction of GFP, YFP, RFP or CFP or double induction of DN-Maml1 784 
with one of the 4 Confetti fluorescent proteins (Confetti-DN-Maml1). Whole tissues were processed 785 
and imaged as above (Whole mount sample preparation and Confocal microscopy). The area of 786 
Confetti clones enclosed or at the edges of DN-Maml1 clones was measured using Volocity 3D Image 787 
Analysis Software (Perkin Elmer). Only red and yellow Confetti clones were quantified.  788 
 789 
Whole tissue YFP clones number and projected areas. To measure the number and size of the YFP 790 
clones from the entire mouse esophageal epithelium we developed the following pipeline. Whole 791 
mouse esophageal epithelia were prepared as described above (Whole mount sample preparation). 792 
A high precision motorised stage coupled to a Leica TCS SP8 confocal microscope was used to obtain 793 
contiguous 3D images of all epithelial layers (basal + suprabasal) from the entire mouse esophagus, 794 
that were later merged using the mosaic function of the Leica Software. Typical settings for 795 
acquisition of multiple z stacks were 1µm z-step size, zoom x1, optimal pinhole, line average 4, scan 796 
speed 400 Hz and a resolution of 1,024 × 1,024 pixels using a 10X HC PL Apo CS Dry objective with a 797 
0.4NA. The Leica LIF files containing the merged images were then processed using Volocity 3D 798 
Image Analysis Software. To identify individual clones and measure their projected surface area 799 
images were opened using the “extended focus” visualization mode on the Volocity 3D software. 800 
Clones were then identified with the “find objects” function using a lower and upper intensity 801 
threshold of 25 and 255, respectively, with a minimum object size of 50µm2 and a restrictive radius 802 
of 10µm.  803 
 804 
In vivo transgenic label-retaining cell assay. Rosa26M2rtTA/TetO-HGFP mice were used to measure 805 
the rate of cell division in the EE following DEN treatment. These mice are double transgenic for a 806 
reverse tetracycline-controlled transactivator (rtTA-M2) targeted to the Rosa 26 locus and a 807 
HIST1H2BJ/EGFP fusion protein (Histone-Green Fluorescent Protein, HGFP) expressed from a 808 
tetracycline promoter element. Treatment of these mice with doxycycline (Doxy, Sigma Aldrich Cat# 809 
D9891) induces the transient expression of HGFP, resulting in nuclear fluorescent labelling 810 
throughout the entire epithelium. When Doxy is withdrawn, HGFP is no longer expressed and is 811 
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diluted lineally by half after every cell division cycle. Therefore, the decline in fluorescence intensity 812 
can be measured to calculate the cell division rate. Rosa26M2rtTA/TetO-HGFP mice received DEN or 813 
sweetened water for 2 months as described above. 2 months after finishing the treatments all mice 814 
were administered Doxy (2mg/ml) in sweetened water for 4 weeks. Mice were culled and tissues 815 
collected either immediately (t = 0) or 7 days (t =7) after Doxy withdrawal (time post-DEN = 3 816 
months). Esophagus were peeled, fixed and stained as detailed above and imaged on a confocal 817 
microscope using a 40x objective. Tissues were stained with CD45 antibody to label immune cells, 818 
which were excluded from the quantifications. The intensity of HGFP in individual basal cells was 819 
analysed using ImageJ. The average proliferation rate in control and DEN tissues was calculated 820 
using the ratios between the HGFP intensity of cells at times 0 and 7 days. Between 2599 and 4766 821 
basal cells were analysed per condition and time point from 2-3 animals and 8 images per tissue.  822 
 823 
EdU lineage tracing assay. EdU (5-ethynyl-2′-deoxyuridine) incorporates into dividing cells, present 824 
only at the EE basal layer (Fig. 1a). EdU labelled cells can then stay in the basal layer or stratify 825 
upwards into the suprabasal layer. The number of EdU positive cells can therefore be used to 826 
quantify proliferation and differentiation rates in the esophageal epithelium of DEN-treated mice. 827 
Wild type animals received DEN for 2 months as described above. 6 months after DEN treatment 828 
mice were administered 10µg of EdU (i.p.) and the esophagus were collected 48h later. Tissues were 829 
peeled, fixed and EdU detected in wholemounts using a Click-iT EdU imaging kit (Life technologies 830 
Cat# C10086) according to the manufacturer’s instructions and imaged by confocal microscopy. The 831 
number of epithelial cells positively stained for EdU was quantified in the basal and suprabasal layers 832 
using Volocity 3D software. A total of 1873 and 2080 EdU positive cells (5 images per animal, 6 833 
animals per group) were counted from control and DEN-treated mice, respectively. Proliferation was 834 
measured as the total number of EdU positive cells present in both basal and suprabasal layers, 835 
whereas the differentiation rate was calculated by dividing the number of EdU positive suprabasal 836 
cells by the total (basal + suprabasal) EdU positive cells. 837 
 838 
Detection of apoptosis by activated caspase-3 staining. Mice were treated with DEN for 2 months 839 
and tissues collected 10 days after DEN withdrawal. Whole mounted esophageal epithelia were 840 
stained for activated caspase-3 and imaged by confocal microscopy. The number of caspase-3 841 
positive cells in the basal layer was quantified with ImageJ. A total of 5355 cells were analysed from 842 
11 images per mouse across the whole esophageal epithelium (n=2 mice). 843 
 844 
Targeted sequencing of mouse esophageal epithelium grid samples.  845 
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 846 
Sample preparation. Mice esophagus were dissected and cut longitudinally before removing the 847 
muscle layer. The entire tissue was then incubated for 2–3 h in 5 mM EDTA at 37 °C before 848 
separating the epithelium from the underlying submucosa with fine forceps. The whole epithelium 849 
was then flattened, fixed in 4% paraformaldehyde for 30 min at room temperature and kept in PBS 850 
at 4 °C. For sequencing, the esophageal epithelium was mapped and cut in 2mm2 contiguous 851 
biopsies (Fig. 1c). Samples were digested and DNA extracted using the QIAMP DNA microkit (QIAGEN 852 
Cat# 56304) following manufacturer’s instructions. DNA from the ears of the same mice was 853 
extracted with the same method and used as germline controls.   854 
 855 
DNA sequencing and coverage metrics. We used an Agilent SureSelect custom bait capture 856 
comprising 192 genes designed to include frequently mutated genes in cancer (Extended Data 1e). 857 
Samples were multiplexed and sequenced on an Illumina HiSeq 2500 sequencer using paired-end 75-858 
bp reads. Paired-end reads were aligned with BWA-MEM (v0.7.17, https://github.com/lh3/bwa) 859 
5with optical and PCR duplicates marked using Biobambam2 (v2.0.86, 860 
https://gitlab.com/german.tischler/biobambam2, 861 
https://www.sanger.ac.uk/science/tools/biobambam). The median coverage across all samples and 862 
genes after removing off-target reads, PCR duplicates and reads with mapping quality <25 and base 863 
quality <30 was 485.5x, ranging from 445-519x between individuals (Extended Data 1f). 864 
 865 
Single clone isolation and whole exome sequencing.  866 
 867 
Sample preparation and imaging. AhcreERTR26flConfetti/wt and AhcreERTR26flEYFP/wt (YFP-Cre) mice were 868 
treated with DEN in drinking water 3 times a week for 8 weeks as described above. After DEN 869 
removal mice were induced by an intraperitoneal (i.p.) injection of 80 mg kg−1β-naphthoflavone and 870 
1 mg tamoxifen. 9 or 18 months after induction animals were culled and tissues harvested. 871 
Esophagus were incubated for 2–3 h in 5 mM EDTA at 37 °C before removing the submucosa from 872 
the epithelium as described above. Confetti or YFP labelled clones were imaged on a fluorescent 873 
scope equipped with the appropriate filters. The projected area of the clones was measured using 874 
Volocity 3D Image Analysis Software.  875 
 876 
Single clone isolation and sequencing. Clones were manually cut under a fluorescent micro-877 
dissecting scope (Leica Microsystems) using ultra fine forceps and micro-scalpels. Individual clones 878 
were collected in low binding DNA tubes and digested in 3 µl RLT buffer (Qiagen Cat# 1048449) for 879 
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30min at room temperature. Digested samples were diluted 1:10 in water, separated in triplicates, 880 
transferred to 96-well plates and incubated 15 min at room temperature with Agencourt AMPure XP 881 
magnetic beads (Beckman Coulter Cat# A63881) at a 1:1 ratio. Beads with bound DNA were 882 
separated with a magnet and washed 3 times with 70% ethanol. DNA was resuspended in 10 µl 883 
elution buffer and transferred to a new plate. Whole genome DNA was amplified using 1 µl 884 
polymerase enzyme from the illustra GenomiPhi V2 DNA Amplification Kit (GE Healthcare Cat# 25-885 
6600-32) and 9 µl of sample with the following conditions: 95 °C for 3 min, 4 °C for 5 min, 30 °C for 886 
1.5 hours and 65 °C for 10min. DNA was then purified by mixing with beads at a 1:0.6 DNA/beads 887 
ratio followed by 3 washes with 70% ethanol and eluted with 30 µl of elution buffer (Qiagen Cat# 888 
19086). Whole-exome sequencing was performed using the Mouse_Exome_Targets baitset from the 889 
Wellcome Sanger Institute pipeline. Captured material was sequenced on Illumina HiSeq 2500 890 
sequencers using paired-end 75bp reads.  891 
 892 
Mutation calling, sequence analysis and missense codon distribution in Notch1 893 
Detailed bioinformatic methods are given in section 2 of the Supplementary note. 894 
 895 
Statistical analysis. Data are expressed as mean values ± SEM unless otherwise indicated. No 896 
statistical method was used to predetermine sample size. The experiments were not randomized. 897 
The investigators were not blinded to allocation during experiments and outcome assessment. 898 
 899 
Data availability. Accession numbers for the targeted sequencing of mouse gridded samples and 900 
WES of isolated single clones are ENA:ERP022921 and ENA:ERP015469, respectively. Individual data 901 
sets are available in Supplementary Tables 1-15. 902 
  903 
Code availability. The code developed in this study has been made publicly available and can be 904 
found at https://github.com/gp10/ClonalCOMMUTE and http://doi.org/10.5281/zenodo.3648706. 905 
 906 
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Confetti clones, 9 months post DEN
(5 mice)
YFP clones, 18 months post DEN
(3 mice)
YFP clones,
9 months post DEN
(4 mice)
Average mutations/clone ± SEM = 402 ±15
Total mutations = 100544
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ABCB11 ABCC2 ADAM10 ADAM29 ADCY10 AFF3 AJUBA AKAP9 AKT1 AKT2 APOB ARID1A
ARID2 ARID5B ASXL1 ATM ATP2A2 ATRX AURKA B2M BBS9 BCAS3 BCL11B BCR
BRAF BRCA2 C1S CACNA1D CARD11 CASP8 CCND1 CDC16 CDH1 CDKN2A CHUK CLGN
CNOT1 CNTNAP4 COBLL1 COL12A1 COPB2 CR2 CREBBP CSMD2 CTCF CUL3 CYLD CYP2B13
DCLK1 DCLRE1A DDR2 DICER1 DMXL2 DNM2 DNMT3A DST EGFR EIF2D EP300 EPHA2
ERBB2 ERBB3 ERBB4 EZH2 FAT1 FAT4 FBN2 FBXO21 FBXW7 FGFR1 FGFR2 FGFR3
FLG2 FLT3 FN1 GCN1L1 GRIN2A GRM3 GTF3C5 HIST1H2BM HMCN1 HRAS HUWE1 HYDIN
IGSF1 INSRR IQGAP1 IRF6 KCNH5 KDM5B KDM6A KDR KEAP1 KIT KLRC3 KMT2C
KMT2D KRAS KRT5 KRTAP4-9 LOXHD1 LRP1 LRP1B LRP2 LTF MAML1 MCM7 MET
MRGPRB4 MTOR MYOF NF1 NF2 NFE2L2 NFKB1 NLRP12 NOTCH1NOTCH2NOTCH3 NOTCH4
NRAS NSD1 NUP214 OPN3 PARD3 PCDHA5 PCED1B PDE4DIP PEG10 PIGN PIK3CA PKHD1
PLCB1 PREX2 PSME4 PTCH1 PTEN PTPRT RAC1 RASA1 RB1 RBM46 RHBDF2 RIPK2
RIPK4 ROS1 RPGRIP1 RPL10 RYR2 SALL1 SCN10A SCN11A SCN1A SCN3A SETD2 SETX
SGK3 SIS SLC13A1 SMAD4 SMARCA4 SMO SNX25 SOAT2 SOX2 SPEN ST18 SUFU
SYNM TAF2 TAS2R102 TET2 TNR TRP53 TRP63 TRRAP TSC1 TTC27 USP24 USP26
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